Jane Street
PALI icon

Jane Street’s Palisade Bio PALI Stock Holding History

Jane Street’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-410,761
Closed -$719K – 12715
2026
Q1 		$719K Buy
410,761
+67,075
+20% +$122K ﹤0.01% 7224
2025
Q4 		$808K Buy
+343,686
New +$661K ﹤0.01% 6591
2022
Q2 		– Sell
-48
Closed -$38K – 10536
2022
Q1 		$38K Buy
48
+18
+60% +$14.5K ﹤0.01% 9769
2021
Q4 		$29K Buy
+30
New +$52.4K ﹤0.01% 9704
2018
Q1 		– Hold
0
– -$39K – 5242
2017
Q4 		– Hold
0
– – – 4444
2015
Q3 		– Hold
0
– -$72K – 3998
2015
Q2 		– Hold
0
– – – 3485
2014
Q4 		– Hold
0
– -$33K – 2880
2014
Q3 		– Hold
0
– – – 2447
2014
Q2 		– Hold
0
– – – 1158
2014
Q1 		– Hold
0
– – – 803

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jane Street's PALI Position: Q2 2026 in Review

Jane Street sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 410,761 shares — an estimated $719K sold.

Jane Street first reported a position in PALI in Q4 2021 and held it in 4 quarters. The position peaked at $808K in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Jane Street reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 410,761 Palisade Bio shares in Q2 2026, an estimated $719K.
  • Jane Street first reported a position in Palisade Bio in Q4 2021 and held it in 4 quarters.
  • Jane Street's Palisade Bio position peaked at $808K in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.